ARIA stock is having a field day as rumors regarding a buyout continue to swirl.

The deal is expected to be complete this coming February, offering Takeda a wide array of drugs and treatments related to hematology, as well as products to treat tumors. There are two Ariad therapies that are key to the deal as they are innovative and effective.

Mylan - Wikipedia

The boards of directors of both companies have green-lit the move, which will be complete unless regulators do not approve the acquisition, which is unlikely. Sarissa Capital Management — stakeholder of 6. Article printed from InvestorPlace Media, http: Financial Market Data powered by FinancialContent Services, Inc.

Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Stocks to Buy Stocks to Sell Dividend Stocks Penny Stocks Hot Stocks Stock Market Today.

Breaking news sponsored by googletag.

ARIAD Pharmaceuticals Inc - :ARIA - Stock Quote & News - TheStreet

Jan 9, , 9: Advanced Micro Devices, Inc. View and vote in our How confident are you about the U. Choose A Page About Us Press Center Resources Advisory Services Free Newsletters Free Reports Contact Us Advertise With Us Employment Privacy Terms and Conditions Disclosures and Disclaimers Media Sites Sitemap jQuery " footer-links".